Hetero Drugs Ltd. - Unit 1

FDA Regulatory Profile

Hetero Drugs Ltd. - Unit 1 appears in FDA public data with 1 recall, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0453-2017, Class III) was initiated on December 29, 2016.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0453-2017Class IIIFinasteride Tablets, USP 5 mg, 90-count bottles, Rx only, Manufactured for : Camber Pharmaceuticals,December 29, 2016